Insulin lispro - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
HUMALOG insulin lispro 100 IU/mL injection multidose vial AUST R: 53488Active ingredients:
Insulin lispro
Dosage form:
Injection, solution
Sponsor:
Eli Lilly Australia Pty Ltd
Phone:
1800454559
|
Deletion from market:
31 Aug 2026
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative presentations available. Patients are advised to consult their healthcare professional to discuss alternative treatment options.
|